Drug Development Tools


  • Drug Development Tool (DDT): Animal Model Qualification Program
  • Drug Development Tool (DDT): Biomarker Qualification Program
  • Drug Development Tool (DDT): Clinical Outcomes Assessment Program

Please submit comments for any of the guidances posted in the Drug Development Tools website to the Division of Dockets Management (DDM) under Docket FDA-XXXX-X-XXXX-XXXX. For electronic comments refer to the website http://www.regulations.gov OR you can mail your written comments to DDM (HFA-305), FDA, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please contact the Regulations.gov HelpDesk at 1-877-378-5457 (toll free) for assistance regarding submissions. 


Drug Development Tools Qualification of BiomarkerPlasma Fibrinogen in Studies Examining Exacerbations and/or All-Cause Mortality in Patients With Chronic Obstructive Pulmonary Disease Draft Guidance for Industry (PDF - 40KB) Draft Guidance 07/02/15
Procedural /Clinical/Medical Qualification Process for Drug Development Tools (PDF - 499KB) Final Guidance 01/06/14

Page Last Updated: 07/06/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.